ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,255,836 | -11.6% | 3,836,377 | +56.7% | 0.00% | 0.0% |
Q2 2023 | $5,948,259 | -37.0% | 2,447,843 | +49.3% | 0.00% | 0.0% |
Q1 2023 | $9,445,698 | -35.3% | 1,639,878 | +0.5% | 0.00% | -50.0% |
Q4 2022 | $14,590,564 | -38.2% | 1,632,054 | -1.7% | 0.00% | -33.3% |
Q3 2022 | $23,616,000 | -1.0% | 1,660,677 | +1.6% | 0.00% | 0.0% |
Q2 2022 | $23,853,000 | +7877.6% | 1,633,737 | +10823.6% | 0.00% | – |
Q1 2022 | $299,000 | +19.6% | 14,956 | +4.3% | 0.00% | – |
Q4 2021 | $250,000 | +103.3% | 14,335 | -8.0% | 0.00% | – |
Q3 2021 | $123,000 | -20.1% | 15,578 | +4.3% | 0.00% | – |
Q2 2021 | $154,000 | +2466.7% | 14,932 | +3037.0% | 0.00% | – |
Q1 2021 | $6,000 | -97.3% | 476 | -97.0% | 0.00% | – |
Q4 2020 | $222,000 | +93.0% | 15,791 | +63.3% | 0.00% | – |
Q3 2020 | $115,000 | – | 9,670 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |